Corrigendum to "De novo metastatic breast cancer in patients with a small locoregional tumour (T1-T2/N0): characteristics and prognosis" [Eur J Cancer 158 (2021) 181-188]

T Gaillard; M Carton; A Mailliez; I Desmoulins; M A Mouret-Reynier; T Petit; M Leheurteur; V Dieras; J M Ferrero; L Uwer; S Guiu; A Gonc Alves; C Levy; M Debled; F Dalenc; A Patsouris; T Bachelot; J C Eymard; M Chevrot; A Conversano; M Robain; D Hequet

doi:10.1016/j.ejca.2022.02.021

Corrigendum to "De novo metastatic breast cancer in patients with a small locoregional tumour (T1-T2/N0): characteristics and prognosis" [Eur J Cancer 158 (2021) 181-188]

Eur J Cancer. 2022 May:166:311-312. doi: 10.1016/j.ejca.2022.02.021. Epub 2022 Mar 18.

Authors

T Gaillard¹, M Carton², A Mailliez³, I Desmoulins⁴, M A Mouret-Reynier⁵, T Petit⁶, M Leheurteur⁷, V Dieras⁸, J M Ferrero⁹, L Uwer¹⁰, S Guiu¹¹, A Gonc Alves¹², C Levy¹³, M Debled¹⁴, F Dalenc¹⁵, A Patsouris¹⁶, T Bachelot¹⁷, J C Eymard¹⁸, M Chevrot¹⁹, A Conversano²⁰, M Robain¹⁹, D Hequet²¹

Affiliations

¹ Department of Surgical Oncology, Institut Curie, Paris & Saint-Cloud, France; Inserm U900, Cancer et Génome: Bioinformatique, Biostatistiques et épidémiologie, Institut Curie, Saint-Cloud, France. Electronic address: [email protected].
² Department of Biostatistics, Institut Curie, Paris & Saint-Cloud, France.
³ Department of Medical Oncology, Centre Oscar Lambret, Lille, France.
⁴ Department of Medical Oncology, Centre Georges-Franc¸ois Leclerc, Dijon, France.
⁵ Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand, France.
⁶ Department of Medical Oncology, ICANS Centre Paul Strauss, Strasbourg, France.
⁷ Department of Medical Oncology, Centre Henri Becquerel, Rouen, France.
⁸ Department of Medical Oncology, Centre Euge`ne Marquis, Rennes, France.
⁹ Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France.
¹⁰ Department of Medical Oncology, Institut de Cance´rologie de Lorraine, Nancy, France.
¹¹ Department of Medical Oncology, Institut de Cance´rologie de Montpellier, Montpellier, France.
¹² Department of Medical Oncology, Institut Paoli Calmette, Marseille, France.
¹³ Department of Medical Oncology, Centre Franc¸ois Baclesse, Caen, France.
¹⁴ Department of Medical Oncology, Institut Bergonie', Bordeaux, France.
¹⁵ Department of Medical Oncology, IUCT-Oncopole Institut Claudius Regaud, Toulouse, France.
¹⁶ Department of Medical Oncology, Institut de Cance´rologie de l'Ouest, Angers & Nantes, France.
¹⁷ Department of Medical Oncology, Centre Le´on Be´rard, Lyon, France.
¹⁸ Department of Medical Oncology, Institut Jean Godinot, Reims, France.
¹⁹ Real World Data Department, Unicancer Data Office, Paris, France.
²⁰ Department of Medical Oncology, Gustave Roussy, Villejuif, France.
²¹ Department of Surgical Oncology, Institut Curie, Paris & Saint-Cloud, France; Inserm U900, Cancer et Génome: Bioinformatique, Biostatistiques et épidémiologie, Institut Curie, Saint-Cloud, France.

PMID: 35314113
DOI: 10.1016/j.ejca.2022.02.021

No abstract available

Publication types

Published Erratum